Skip to ContentSkip to Navigation
How to find us prof. dr. A.L.W. (Anke) Huckriede

Publications

Advances in the development of entry inhibitors for sialic-acid-targeting viruses

COVID-19 vaccination: the VOICE for patients with cancer

In vitro assessment of tick-borne encephalitis vaccine: Suitable human cell platforms and potential biomarkers

Characterization of humoral immune responses and degree of protection induced by influenza vaccine in cotton rats: Effects of low vaccine dose and single vs booster vaccination

Comparison of influenza-specific neutralizing antibody titers determined using different assay readouts and hemagglutination inhibition titers: good correlation but poor agreement

Development of an Orodispersible Film Containing Stabilized Influenza Vaccine

Vaccins tegen SARS-CoV-2

A PBMC-Based System to Assess Human T Cell Responses to Influenza Vaccine Candidates In Vitro

Cross-Protective Potential and Protection-Relevant Immune Mechanisms of Whole Inactivated Influenza Virus Vaccines Are Determined by Adjuvants and Route of Immunization

Enhanced Antiviral Activity of Human Surfactant Protein D by Site-Specific Engineering of the Carbohydrate Recognition Domain

Read more

Press/media

Intravacc announces formation of Scientific Advisory Board

Pas veel minder maatregelen na meer prikken: welke vaccins komen er nog aan?

Vaccin beschermt ook tegen Britse variant, maar experts zijn nog niet helemaal gerust

Pfizer-vaccin lijkt te werken tegen mutatie Britse en Zuid-Afrikaanse variant

Zorgen over mutaties: 'De vraag is of we in de stilte voor de storm zitten'

Ook Europa kan nu denken aan begin van het einde van het coronavirus

Allergische reacties op Pfizer-vaccin: mogelijk kwartier nablijven na inenting ter controle

Duizenden therapeuten krijgen desinformatie over corona tijdens verplichte bijscholingen

Zeven vragen over het RNA-vaccin

Read more